Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Warrant Exercise

13 Nov 2015 15:35

RNS Number : 7318F
Imaginatik PLC
13 November 2015
 

Imaginatik Plc

 

("Imaginatik" or "the Company")

 

Warrant Exercise

 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of consultancy and technology products, announces that it has issued 413,491 new ordinary shares of 1 pence each in the share capital of the Company ("Ordinary Shares") following the exercise by Daniel Stewart Securities plc of its warrant over new shares in the Company granted to Daniel Stewart Securities plc at the time of the Company's subscription on 14 May 2015. The warrants have an exercise price of 2.7 pence per share, the same price as the Company's subscription price. As a result of the warrant exercise, the Company will receive cash proceeds on exercise of £11,164. There are no further outstanding warrants in issue.

The total number of Ordinary Shares following Admission will be 85,111,585. Accordingly the figure of 85,111,585 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

Application has been made for the new Ordinary Shares to be admitted to AIM, with trading expected to commence on 19 November 2015 ("Admission"). Upon Admission, the shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.

 

For further information please contact:

 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

 

finnCap Ltd

Tel: 020 7220 0500

Jonny Franklin-Adams/Giles Rolls

 

Daniel Stewart & Company

Tel: 020 7776 6550

Martin Lampshire/David Coffman

 

Alma PR

Tel: 020 7796 9085

Hilary Buchanan

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, Exxon Mobil, Altria, Shell, Mayo Clinic, Goodyear, the Yorkshire Building Society, Pitney Bowes and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBJBATMBJBBJA
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.